ELND005

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2016
0120112016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND ELND005 (scyllo-Inositol; cyclohexane-1,2,3,4,5,6-hexol) has been evaluated as a potential disease-modifying treatment… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2016
Review
2016
INTRODUCTION Agitation is common and distressing in persons with dementia, but safe, effective treatments remain elusive. In this… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2013
2013
ELND005 (scyllo-inositol), an endogenous inositol stereoisomer, is being investigated as an oral treatment for Alzheimer's… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2011
Highly Cited
2011
OBJECTIVE This randomized, double-blind, placebo-controlled, dose-ranging phase 2 study explored safety, efficacy, and biomarker… (More)
Is this relevant?